As of January 23, 2025, Medesis Pharma SA (ALMDP.PA) has a market cap of $2.023 million USD. According to our data, Medesis Pharma SA is ranked No.9185 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $2.02 M |
14.37%
|
Dec 31, 2024 | $1.77 M |
-61.98%
|
Dec 29, 2023 | $4.65 M |
-56.07%
|
Dec 30, 2022 | $10.59 M |
-61.71%
|
Dec 31, 2021 | $27.65 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
First Majestic Silver
AG
|
$2.70 B |
10.900 M
|
Canada
|
Takeda Pharmaceutical
TAK
|
$40.87 B |
0.001 M
|
Japan
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Market Cap | = | ALMDP.PA Stock Price | * | ALMDP.PA Shares Outstanding |
= | $0.36 | * | 5.15 M | |
= | $2.02 M |